LINSEY PHILIP: Open Payments
NPI 1053304469 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 38 payments from 6 companies in 2025. Trend: 2023 $782 · 2024 $1,397 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $235 |
| Novo Nordisk Inc | 13 | $191 |
| Otsuka America Pharmaceutical, Inc. | 12 | $179 |
| Gilead Sciences, Inc. | 7 | $167 |
| ViiV Healthcare Company | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: REXULTI, Wegovy, Biktarvy, AIRSUPRA, BREZTRI, Ozempic, DOVATO, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
